| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 02/02/2005 | EP1501818A1 Alkylene carbonate purification method |
| 02/02/2005 | EP1501786A1 Biphenyl carboxamides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2004108673A3 Inhibitors of papilloma virus |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020855 Process for producing a fluorine-containing compound by liquid phase fluorination |
| 01/27/2005 | US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020609 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571764A Novel norbornane and norbornene derivatives, use thereof and perfumed products containing same |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1569863A Method for preparing platinum(II) metal complex eptaplatin |
| 01/26/2005 | CN1569851A Supported catalyst for preparation of carbonic alkenyl ester and method for preparing same |
| 01/26/2005 | CN1569332A Solid catalyst for preparing dialkyl carbonate and its application |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014791 Inhibitors of papilloma virus |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/20/2005 | US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014210 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/20/2005 | CA2531790A1 Compound having anti-hcv action and its production method |
| 01/19/2005 | EP1498415A1 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1498121A1 Use of specific cyclolignans |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1423377B1 Method for producing glycerol carbonate |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | CN1566111A Preparation method of cyclic carbonate |
| 01/19/2005 | CN1566110A Process for synthesizing cyclic carbonate |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/18/2005 | US6844375 Emission-free, photocationic crosslinkers for production of solvent-resistant and transparent films |
| 01/18/2005 | US6844366 Such as N-hydroxy-2(R)-((3,4-methylenedioxybenzyl)-(4-methoxy-2,3,6-trimethylbenzene-sulfonyl) amino)-3-methylbutyramide for treatment of diseases treatable with pro-collagen C-proteinase inhibitors |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009729 Cosmetics; cleaning compounds; indeno(4,5-d)-1,3-dioxole |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/12/2005 | EP1496055A1 Acetonide fragrance compound |
| 01/12/2005 | EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | CN1562998A Method for synthesizing compound in condensed carbonyl group |
| 01/12/2005 | CN1562997A 1, 3-dioxolane-2, 2-dimethylalcohol, preparation method and usage |
| 01/11/2005 | US6841703 Polymerization of ethylenically unsaturated monomers with low dispersity |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841667 Nucleophilic kinetic resolution of cyclic substrates using silyl azides |
| 01/06/2005 | WO2005000804A2 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | WO2005000777A2 Process for the preparation of cinnamaldehyde compounds |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | US20050004385 Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same |
| 01/06/2005 | US20050004379 Chemical intermediates for drugs; neurological disorders; psychological disorders |
| 01/06/2005 | US20050004378 woody or amber odor; hydrogentation, reduction; cosmetic and care products |
| 01/06/2005 | US20050004375 Irradiating organic carbonate, such as ethylene carbonate or propylene carbonate, with ultraviolet radiation |
| 01/06/2005 | US20050004183 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | CA2529086A1 Process for the preparation of cinnamaldehyde compounds |
| 01/06/2005 | CA2526988A1 Substituted indoles and a process for preparing substituted indoles |
| 01/05/2005 | EP1493731A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and these derivatives |
| 01/05/2005 | EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 01/05/2005 | EP1127060B8 Hydroboronation process |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1182916C High-activity catalyst for synthesizing cyclic carbonic acid ester in mild condition |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266844 Antimicrobial and radioprotective compounds |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266784 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1490323A1 A low corrosive integrated process for preparing dialkyl carbonates |
| 12/29/2004 | CN1558895A Compositions for treating acne comprising phytandiol amine |
| 12/29/2004 | CN1182133C Process for preparing dihydro-safrole by catalysis hydrogenation |